Loading…
Operates in Medical Devices. Per the activity note to the FY2024 annual report, the company sells interventional cardiology consumable materials.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,832 | 4,174 | 3,494 | 6,882 | 5,575 | 6,236 | 6,924 | +10.4% |
| Total COGS | 2,543 | 2,746 | 2,444 | 5,346 | 3,843 | 4,040 | 4,516 | +10.0% |
| Gross Profit | 1,289 | 1,427 | 1,050 | 1,536 | 1,732 | 2,196 | 2,408 | +11.0% |
| Gross Margin | 33.6% | 34.2% | 30.0% | 22.3% | 31.1% | 35.2% | 34.8% | |
| 185 | 187 | 179 | 181 | 244 | 287 | 247 | +4.9% | |
| EBITDA | 1,103 | 1,241 | 871 | 1,355 | 1,487 | 1,909 | 2,161 | +11.9% |
| EBITDA Margin | 28.8% | 29.7% | 24.9% | 19.7% | 26.7% | 30.6% | 31.2% | |
| Total D&A | 9 | 8 | 7 | 9 | 6 | 10 | 10 | +2.1% |
| EBIT / Operating Income | 1,094 | 1,233 | 864 | 1,346 | 1,482 | 1,899 | 2,151 | +11.9% |
| Total Interest Income | 0 | 0 | 0 | 0 | 0 | 35 | 70 | +100.6% |
| Total Interest Expense | 0 | 0 | 0 | 3 | 0 | 0 | 15 | +68.4% |
| 59 | 78 | 21 | 33 | 18 | 13 | 37 | -7.6% | |
| Profit Before Tax | 1,036 | 1,155 | 843 | 1,309 | 1,464 | 1,921 | 2,170 | +13.1% |
| Total Income Tax | 1 | 81 | 43 | 78 | 61 | 85 | 89 | +99.6% |
| Net Profit / (Loss) | 1,033 | 1,074 | 796 | 1,234 | 1,405 | 1,810 | 2,035 | +12.0% |
| Net Margin | 26.9% | 25.7% | 22.8% | 17.9% | 25.2% | 29.0% | 29.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →